|
|
 |
|
Total Number of Holdings (excluding cash): 49
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
752 |
$67,680.00 |
3.56% |
| Align Technology, Inc. |
ALGN |
016255101 |
338 |
$56,402.06 |
2.97% |
| Penumbra, Inc. |
PEN |
70975L107 |
163 |
$53,783.48 |
2.83% |
| Masimo Corporation |
MASI |
574795100 |
294 |
$52,546.62 |
2.76% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$51,597.85 |
2.71% |
| Waters Corporation |
WAT |
941848103 |
159 |
$48,873.42 |
2.57% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
576 |
$46,563.84 |
2.45% |
| Hologic, Inc. |
HOLX |
436440101 |
612 |
$46,512.00 |
2.45% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,885 |
$45,986.81 |
2.42% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
99 |
$44,842.05 |
2.36% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,046 |
$44,620.14 |
2.35% |
| Alcon Inc. |
ALC.SW |
H01301128 |
589 |
$43,789.30 |
2.30% |
| The Cooper Companies, Inc. |
COO |
216648501 |
622 |
$43,328.52 |
2.28% |
| Revvity, Inc. |
RVTY |
714046109 |
482 |
$42,314.78 |
2.23% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
163 |
$42,274.05 |
2.22% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
599 |
$41,768.27 |
2.20% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
33 |
$41,910.00 |
2.20% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,550 |
$41,567.92 |
2.19% |
| DexCom, Inc. |
DXCM |
252131107 |
654 |
$41,273.94 |
2.17% |
| Teleflex Incorporated |
TFX |
879369106 |
356 |
$41,121.56 |
2.16% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
449 |
$41,038.60 |
2.16% |
| Danaher Corporation |
DHR |
235851102 |
210 |
$40,112.10 |
2.11% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
143 |
$39,754.00 |
2.09% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
81 |
$39,649.50 |
2.09% |
| Steris Plc |
STE |
G8473T100 |
180 |
$39,459.60 |
2.08% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
393 |
$39,462.55 |
2.08% |
| Stryker Corporation |
SYK |
863667101 |
117 |
$38,852.19 |
2.04% |
| Medtronic Plc |
MDT |
G5960L103 |
446 |
$38,543.32 |
2.03% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,415 |
$38,282.40 |
2.01% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
196 |
$37,564.70 |
1.98% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
539 |
$36,328.60 |
1.91% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,560 |
$35,695.92 |
1.88% |
| Agilent Technologies, Inc. |
A |
00846U101 |
312 |
$35,530.56 |
1.87% |
| Becton, Dickinson and Company |
BDX |
075887109 |
228 |
$35,330.88 |
1.86% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,205 |
$35,429.36 |
1.86% |
| ResMed Inc. |
RMD |
761152107 |
156 |
$35,263.80 |
1.86% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,540 |
$34,674.55 |
1.82% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
157 |
$34,650.60 |
1.82% |
| BioMerieux |
BIM.FP |
F1149Y232 |
320 |
$33,948.61 |
1.79% |
| Abbott Laboratories |
ABT |
002824100 |
321 |
$32,687.43 |
1.72% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
778 |
$32,419.67 |
1.71% |
| Baxter International Inc. |
BAX |
071813109 |
1,939 |
$32,226.18 |
1.70% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
485 |
$31,996.46 |
1.68% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,434 |
$30,677.26 |
1.61% |
| Boston Scientific Corporation |
BSX |
101137107 |
446 |
$27,589.56 |
1.45% |
| Cochlear Limited |
COH.AU |
Q25953102 |
229 |
$27,634.99 |
1.45% |
| Insulet Corporation |
PODD |
45784P101 |
135 |
$27,332.10 |
1.44% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,487 |
$26,153.76 |
1.38% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
860 |
$24,808.45 |
1.31% |
| Australian Dollar |
$AUD |
|
441 |
$307.96 |
0.02% |
| Euro |
$EUR |
|
13 |
$15.34 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| Swiss Franc |
$CHF |
|
0 |
$0.00 |
0.00% |
| US Dollar |
$USD |
|
-41,490 |
($41,489.87) |
-2.18% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|